Community-associated Staphylococcus aureus infections in otherwise healthy infants less than 60 days old

Cecilia Torres Day; Sheldon L Kaplan; Edward O Mason; Kristina G Hulten

doi:10.1097/INF.0b013e3182a5f9a8

Community-associated Staphylococcus aureus infections in otherwise healthy infants less than 60 days old

Pediatr Infect Dis J. 2014 Jan;33(1):98-100. doi: 10.1097/INF.0b013e3182a5f9a8.

Authors

Cecilia Torres Day¹, Sheldon L Kaplan, Edward O Mason, Kristina G Hulten

Affiliation

¹ From the *Department of Pediatrics, †Sections of Neonatology and ‡Infectious Diseases, Baylor College of Medicine, Texas Children's Hospital, Houston, TX.

PMID: 23934207
DOI: 10.1097/INF.0b013e3182a5f9a8

Abstract

Community-associated (CA)-Staphylococcus aureus (CA-methicillin-resistant S. aureus in 57%) infections were reviewed in 179 infants (0-60 days) from June 2006 to June 2011. CA-MSSA accounted for 16 of 44 (36%) in year 1 up to 12 of 25 (48%) in year 5 (P = 0.08). Abscess/cellulitis infections were more likely (P = 0.006) to be caused by CA-methicillin-resistant S. aureus (67%) versus other manifestations of infections (46%). Among 160 isolates, 13% were clindamycin resistant and 63% were USA300.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
Community-Acquired Infections / diagnosis
Community-Acquired Infections / drug therapy
Community-Acquired Infections / epidemiology
Community-Acquired Infections / microbiology*
Drug Resistance, Bacterial
Humans
Infant
Infant, Newborn
Methicillin-Resistant Staphylococcus aureus / drug effects
Methicillin-Resistant Staphylococcus aureus / isolation & purification
Prospective Studies
Staphylococcal Infections / diagnosis
Staphylococcal Infections / drug therapy
Staphylococcal Infections / epidemiology
Staphylococcal Infections / microbiology*
Staphylococcus aureus / drug effects
Staphylococcus aureus / isolation & purification*
Texas / epidemiology

Substances

Anti-Bacterial Agents